Kolexia
Largeau Berenger
Pharmacien
Centre hospitalier de Tours
Tours, France
54 Activités
140 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Oedème Leucoencéphalopathie postérieure Encéphalopathies Défaillance cardiaque Leucoencéphalopathies Maladies neurodégénératives COVID-19 Effets secondaires indésirables des médicaments Syndrome de fuite capillaire

Industries

{{person.topindus1.name}}
{{person.topindus1.tot}} collaboration(s)
Dernière en {{person.topindus1.last}}
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Experimental Models of Posterior Reversible Encephalopathy Syndrome: A Review From Pathophysiology to Therapeutic Targets.
Stroke   21 décembre 2023
TOPGUN: TOPical Sirolimus in linGUal Microcystic Lymphatic Malformation -TOPGUN
Essai Clinique (CHU Tours)   28 novembre 2023
Drug clustering to anticipate new aspects of drug safety profile: Application to gabapentinoids and other voltage-gated calcium channel ligand drugs.
British journal of clinical pharmacology   23 octobre 2023
Thrombotic microangiopathy associated with anticancer and immune system targeting drugs: New insights from real-world data using the WHO pharmacovigilance database.
Journal of internal medicine   04 août 2023
XPRESSE: The Arginine Vasopressin aXis as a Potential Therapeutic Target for Posterior REverSible Encephalopathy SyndromE (XPRESSE)
Essai Clinique (CHU Tours)   06 juillet 2023
Immune checkpoint inhibitor–associated capillary leak syndrome: A mixed approach combining a systematic review of published case reports and a WHO pharmacovigilance database disproportionality analysis
Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, 12–14 June 2023, Limoges, France   07 juin 2023
Response to Letter "Only blames SARS-CoV-2 vaccination for facial palsy after alternative etiologies have been ruled out".
Therapie   25 mai 2023
Immune checkpoint inhibitor-associated capillary leak syndrome: A systematic review and a worldwide pharmacovigilance study.
Journal of internal medicine   20 avril 2023
Peripheral facial palsy post SARS-CoV-2 vaccine: A regional pharmacovigilance cases series.
Therapie   16 février 2023
COVID-19 Vaccination as a Trigger of IgA Vasculitis: A Global Pharmacovigilance Study.
The Journal of rheumatology   15 novembre 2022